Why Early FDA Engagement Is Make-or-Break for Medical Device Startups

Integrating FDA Compliance Into Medical Device Development From Day One

For medical device startups and early-stage companies, overlooking regulatory requirements during product development can lead to unexpected costs, extended timelines, and significant setbacks when preparing for FDA submissions. Establishing a regulatory strategy early helps manufacturers identify requirements and build a more predictable path to market.

In this article, Jessica Schafersman, subject matter expert at Regulatory Compliance Associates (RCA), a Nelson Labs company, discusses common development challenges and how companies can integrate regulatory compliance into their processes from the beginning.

The discussion highlights the importance of establishing a regulatory strategy before defining design inputs, leveraging FDA pre-submission programs, and incorporating design controls and risk management into early development. Schafersman also emphasizes the need to plan for clinical evidence, establish foundational quality management system (QMS) procedures, and maintain controlled documentation throughout the product lifecycle.

By prioritizing regulatory planning, design controls, and appropriate documentation from the outset, medical device manufacturers can reduce avoidable delays, manage development costs, and better prepare for FDA submissions.

Read the full article:
Why Delaying FDA Compliance Could Blow Your Timeline and Budget